Hayes Christopher G.

Insider profile

Performance

Overall performance
3.4

Performance over holding periods
4.2
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 82% 68% 82%
Transactions
10 20% Buy
34 71% Buy
47 69% Buy
Performance for realised trades
4.4
Average return 70%
Success rate 73%
Average holding period 220
Transactions 28
Hayes Christopher G.'s trades of Verrica Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-03-18 2025-03-17 S Sale
1,722 -11.6%
460.46
US$2,717,863
1,722 -11.6% 460.46 US$2,717,863
2024-08-28 2024-08-27 S Sale
74,782 -44.7%
475.01
US$382,429
74,782 -44.7% 475.01 US$382,429
2024-08-28 2024-08-26 S Sale
29,775 +12.9%
350.17
US$1,905,857
29,775 +12.9% 350.17 US$1,905,857
2024-08-26 2024-08-26 PrS Proposed sale
36,000
2.62
US$94,300
36,000 2.62 US$94,300
2024-07-23 2024-07-23 S Sale
91 -0.1%
6.98
US$635
91 -0.1% 6.98 US$635
2024-07-23 2024-07-22 S Sale
21,649 -13.3%
7.06
US$152,842
21,649 -13.3% 7.06 US$152,842
2024-07-22 2024-07-22 PrS Proposed sale
21,971
6.97
US$153,085
21,971 6.97 US$153,085
2023-11-16 2023-11-15 S Sale
11,558 -8.6%
2.97
US$34,327
11,558 -8.6% 2.97 US$34,327
2023-11-16 2023-11-14 S Sale
22,141 -14.1%
2.93
US$64,873
22,141 -14.1% 2.93 US$64,873
2023-11-15 2023-11-14 PrS Proposed sale
33,798
2.93
US$99,028
33,798 2.93 US$99,028
2023-07-27 2023-07-24 PrS Proposed sale
33,789
4.80
US$162,285
33,789 4.80 US$162,285
2023-07-25 2023-07-24 S Sale
33,789 -29.2%
4.83
US$163,201
33,789 -29.2% 4.83 US$163,201
2022-07-11 2022-07-11 B Purchase
7,500 +91.3%
3.40
US$25,500
7,500 +91.3% 3.40 US$25,500
2022-07-05 2022-07-05 B Purchase
5,714 +228.6%
2.10
US$11,999
5,714 +228.6% 2.10 US$11,999